Richard Straube
Vermögen: 31 $ am 31.05.2026
Vermögen: 31 $ am 31.05.2026
Richard C.
Straube worked as Senior Director-Clinical Research & Immunology at Centocor, Inc. from 1988 to 1993.
From 1993 to 1995, served as Director-Medical Affairs at T Cell Sciences, Inc. Between 1995 and 1997, held the position of Director-Clinical Investigations at Ohmeda, Inc. From 1998 to 2007, was Chief Scientific Officer and Executive VP-R&D at INO Therapeutics LLC.
Held the role of Chief Medical Officer at Critical Biologics Corp.
from 2007 to 2009.
From 2009 to 2014, was Chief Medical Officer at Stealth BioTherapeutics, Inc. Served as Chief Medical Officer & Senior Vice President at Soligenix, Inc. from 2014 to 2025.
Also held positions as Faculty Member at the University of California San Diego and Principal at Inomax LLC (Florida).
Education includes a doctorate from The University of Chicago in 1977 and a graduate degree from the London School of Hygiene & Tropical Medicine in 1982.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.12.2025 | 34 ( 0 % ) | 31 $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| SOLIGENIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.08.2025 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Critical Biologics Corp.
Critical Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
INO Therapeutics LLC
INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
Ohmeda, Inc. | Corporate Officer/Principal | 02.01.1997 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Soligenix, Inc.
Soligenix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biodefense vaccines and oral therapeutic products | Health Technology |
Critical Biologics Corp.
Critical Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics drugs | Health Technology |
T Cell Sciences, Inc.
T Cell Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for diseases of the immune system | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Hygiene & Tropical Medicine
London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INO Therapeutics LLC
INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Inomax LLC (Florida)
Inomax LLC (Florida) Investment ManagersFinance Operates as a venture capital company | Finance |
Ohmeda, Inc. | |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen